首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >Influence of Tunneled Hemodialysis-Catheters on Inflammation and Mortality in Dialyzed Patients
【2h】

Influence of Tunneled Hemodialysis-Catheters on Inflammation and Mortality in Dialyzed Patients

机译:隧道血液透析导管对透析患者炎症和死亡率的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Older age and comorbidities in hemodialysis patients determines the use of tunneled catheters as vascular access despite their reported clinical and mortality disadvantages. This prospective matched study analyzes the impact of permanent catheters on inflammation and mortality in hemodialysis patients; We studied 108 patients, 54 with AV-fistula (AVF) and 54 with indwelling hemodialysis catheters (HDC) matched by sex, age, diabetes and time under renal-replacement therapy comparing dialysis efficacy, inflammation and micro-inflammation parameters as well as mortality. Cox-regression analysis was applied to determine predictors of mortality, HDC patients presented higher C-reactive-protein (CRP) blood levels and percentage of pro-inflammatory lymphocytes CD14+/CD16+ with worse dialysis-efficacy parameters. Thirty-six-months mortality appeared higher in the HDC group although statistical significance was not reached. Age with a Hazard Ratio (HR) = 1.06, hypoalbuminemia (HR = 0.43), hypophosphatemia (HR = 0.75) and the increase in CD14+/CD16+ monocyte count (HR = 1.02) were predictors of mortality; elder patients dialyzing through HDC show increased inflammation parameters as compared with nAVF bearing patients, although they do not present a significant increase in mortality when matched by covariates. Increasing age and percentage of pro-inflammatory monocytes as well as decreased phosphate and serum-albumin were predictors of mortality and indicate the main conclusions or interpretations.
机译:血液透析患者的年龄和可血糖决定使用隧道导管作为血管进入的使用,尽管他们报告了临床和死亡率缺点。该前瞻性匹配研究分析了永久导管对血液透析患者炎症和死亡率的影响;我们研究了108名患者,54名患有AV-Fistula(AVF)和54名,留置血液透析导管(HDC)与肾脏替代治疗下的性别,年龄,糖尿病和时间相匹配,比较透析疗效,炎症和微炎症参数以及死亡率。应用Cox-rescollion分析以确定死亡率的预测因子,HDC患者呈现出更高的C-反应蛋白(CRP)血液水平和促炎淋巴细胞CD14 + / CD16 +的百分比,具有较差的透析效果参数。 HDC集团在HDC集团中出现了36个月的死亡率较高,但没有达到统计显着性。危险比(HR)= 1.06的年龄,低聚蛋白血症(HR = 0.43),次磷血症(HR = 0.75)和CD14 + / CD16 +单核细胞计数(HR = 1.02)的增加是死亡率的预测因子;通过HDC透析的老年患者显示与NAVF患者相比,炎症参数增加,尽管当通过协变量匹配时,它们并未显着增加死亡率。增加年龄和促炎单核细胞的年龄和百分比和磷酸盐和血清白蛋白的降低是死亡率的预测因子,并表明了主要结论或解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号